ArticleBioinformation2026
Evaluation of peri-implant soft tissue thickness and its influence on marginal bone loss: A prospective clinical study.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peri-implant marginal bone loss remains a critical challenge because the quantitative influence of soft tissue thickness on bone stability is not fully established. Hence, this prospective cohort study evaluated 156 implants in 124 patients, categorizing sites into thin (<2 mm) and thick (≥2 mm) mucosal groups, with bone loss assessed radiographically over 24 months. Mean soft tissue thickness was 1.42 ± 0.38 mm in the thin group and 2.89 ± 0.56 mm in the thick group. At 24 months, marginal bone loss was significantly higher in the thin mucosa group (1.78 ± 0.62 mm) compared to the thick mucosa group (0.67 ± 0.34 mm) (p<0.001), with soft tissue thickness identified as an independent predictor. Thus, thin mucosa was associated with a 3.2-fold increased risk of pathological bone loss, indicating the importance of soft tissue assessment in implant treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.